Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06121219 · ClinicalTrials.gov registry record · NA
Effect of Visual Retraining After Stroke
A NA study of Stroke, Ischemic and Hemianopia, sponsored by University of Rochester.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06121219: Recruiting NA study of Stroke, Ischemic and Hemianopia, sponsored by University of Rochester.
NCT06121219 is a NA study of Stroke, Ischemic and Hemianopia that is actively recruiting participants, run by University of Rochester. The registered enrollment target is 100 participants, below the 287-participant average among 33 other Stroke, Ischemic trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06121219, a NA study of Stroke, Ischemic and Hemianopia, is actively recruiting participants, sponsored by University of Rochester.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This project is intended to collect data using standard clinical tests and psychophysics to quantify the effect of visual cortical damage on the structure of the residual visual system, visual perception, spatial awareness, and brain function. The investigators will also assess the effect of intensive visual retraining on the residual visual system, processing of visual information and the use of such information in real-world situations following damage. This research is intended to improve our understanding of the consequences of permanent visual system damage in humans, of methods that can be used to reverse visual loss, and of brain mechanisms by which visual recovery is achieved.
Primary Outcome
For each subject, the investigators will measure the change in ability to detect differences in the motion direction of visual stimuli relative to horizontal, measured in degrees of visual angle with respect to the stimulus. These assessments will be based on what can be reliably detected at a 72-75% correct level of performance on our 2AFC task, with task difficulty adjusted on a 3:1 staircase. The degrees of visual angle for the stimulus vary from 90 degrees (fully vertical) to 0.1 degrees (vi
Conditions Studied
Interventions
- DEVICE Training in the Blind Field
Study Locations (1)
New York
- University of Rochester Medical Center - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-09-05 |
| Est. Completion | 2032-01 |
| Phase | NA |
What NCT06121219 shows while recruiting
NCT06121219 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 287-participant average among 33 other Stroke, Ischemic trials with a reported enrollment target (65% lower).
The record links to 8 conditions, with Stroke, Ischemic appearing as the primary indexed condition, and to 1 intervention - of which Training in the Blind Field is the first listed.
NCT06121219 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06121219 about?
NCT06121219 is a clinical study titled "Effect of Visual Retraining After Stroke". This project is intended to collect data using standard clinical tests and psychophysics to quantify the effect of visual cortical damage on the structure of the residual visual system, visual perception, spatial awareness, and brain function. The investigators will also assess the effect of intensi...
What is the current status of trial NCT06121219?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2024-09-05. Estimated completion is 2032-01.
What conditions does trial NCT06121219 study?
This clinical trial studies the following conditions: Stroke, Ischemic, Hemianopia, Quadrantanopia, Cortical Blindness, Vision Loss Partial.
What interventions are being tested in trial NCT06121219?
The interventions under investigation include: Training in the Blind Field (DEVICE).
Who is sponsoring clinical trial NCT06121219?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06121219 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke, Ischemic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06121219's enrollment target sits among peer trials
100 15th of 33 higher than 18 of 33 other Stroke, Ischemic trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke, Ischemic trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Hand and Arm Motor Recovery Via Non-invasive Electrical Spinal Cord Stimulation After Stroke
RECRUITING · NA
-
The Fourth Left Atrial Appendage Occlusion Study
RECRUITING · NA
-
Vision Loss Impact on Navigation in Virtual Reality
RECRUITING · NA
-
Cognitive Strategies for Optimizing Brain Health And Managing Transgenerational Vascular Risk Factors Post-Stroke
RECRUITING · NA
-
Utility of CC7 Transfer in Stroke Subtypes
RECRUITING · NA
-
Non-invasive Trigeminal and Vagus Nerve Stimulation for Stroke Subjects With Chronic Upper Extremity Deficits
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI